Facilitating the Recovery of Function Following Stroke: The Efficacy of Inosine

促进中风后功能恢复：肌苷的功效

• 批准号: 8536424
• 负责人: TARA L MOORE
• 金额: $ 19.75万
• 依托单位: BOSTON UNIVERSITY MEDICAL CAMPUS
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-09-01 至 2015-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8536424
• 关键词: American; Animal Model; Animals; Area; Axon; Blood Vessels; Brain; Brain Injuries; Brain Stem; Cell membrane; Clinical Research; Clinical Trials; Control Groups; Corticospinal Tracts; Data; Development; Dose; Equilibrium; Experimental Designs; FOS Protein; Funding; Future; Goals; Growth; Hand; Hand functions; Harvest; Hour; Human; Immunohistochemistry; Individual; Infarction; Injection of therapeutic agent; Injury; Inosine; Intervention; Ischemia; Ischemic Stroke; Label; Limb structure; MRI Scans; Macaca mulatta; Manganese; Maps; Methods; Modeling; Monkeys; Motor; Motor Cortex; Multiple Sclerosis; Neurodegenerative Disorders; Neurons; Operative Surgical Procedures; Oral; Oral Administration; Parkinson Disease; Patients; Pattern; Performance; Pharmacologic Substance; Play; Postoperative Period; Process; Property; Protein Kinase; Proteins; Purine Nucleosides; Recovery; Recovery of Function; Recurrence; Research; Rodent; Rodent Model; Role; Serum; Signal Pathway; Signal Transduction; Spinal; Spinal Cord; Stroke; Structure; Study models; Testing; Therapeutic; Therapeutic Agents; Therapeutic Intervention; Tracer; Training; Urate; Uric Acid; axon growth; brain tissue; clinically relevant; disability; experience; improved; ischemic lesion; juvenile animal; middle age; motor function recovery; motor impairment; nerve supply; neuroprotection; nonhuman primate; partial recovery; presynaptic; stroke recovery; synaptogenesis

DESCRIPTION (provided by applicant): Approximately 750,000 Americans experience a new or recurrent stroke each year, and 80% of these experience impairment of motor function of the extremities. Partial recovery of motor function occurs even without pharmacological interventions. Clinical studies and animal models suggest that this recovery results from adaptive plasticity and reorganization in intact cortical areas. At the cellular level, reorganizaton following ischemic injury has been found to correlate with dendritic remodeling, increased levels of presynaptic growth- associated proteins and synaptogenesis in peri-infarct regions. Though the precise mechanisms promoting axonal growth and synaptogenesis are unclear, the relationship between these markers of plasticity and recovery provides compelling evidence for investigating plasticity as a target for therapeutic intervention. The therapeutic agent, inosine, stimulates axonal growth and has been shown to enhance functional recovery in rodent models of stroke. Following unilateral stroke, inosine enhances the ability of neurons in the undamaged hemisphere to extend axon collaterals into brainstem and spinal cord areas that have lost normal innervation. This rewiring is accompanied by improved use of an impaired limb. Inosine is a naturally occurring purine nucleoside that crosses the cell membrane and activates Mst3b, a protein kinase that plays a central role in the cell-signaling pathway through which trophic factors stimulate axonal growth. The plasticity enhancing properties of inosine are currently being tested clinically in patients with multiple sclerosis and Parkinson's Disease (Parkinson's Disease Study Group, 2011; Markowitz et al, 2009). The goal of this proposal is to use our rhesus monkey model of cortical ischemic stroke developed with R21 AG-028680 to explore the efficacy of inosine in the recovery of motor function following cortical ischemia in a gyrencephalic animal with brain structure and fine motor dexterity highly similar to humans. !

描述(申请人提供)：每年约有750,000名美国人经历新发或复发的中风，其中80%经历肢体运动功能障碍。即使没有药物干预，运动功能也会部分恢复。临床研究和动物模型表明，这种恢复是由于完整皮质区域的适应性可塑性和重组所致。在细胞水平上，缺血损伤后的重组与树突状细胞重塑、突触前生长相关蛋白水平的增加以及梗塞周围区域的突触形成有关。尽管促进轴突生长和突触发生的确切机制尚不清楚，但这些可塑性标志物与恢复之间的关系为研究可塑性作为治疗干预的靶点提供了令人信服的证据。这种名为肌苷的治疗剂可刺激轴突生长，并已被证明能促进中风啮齿动物模型的功能恢复。在单侧中风后，肌苷增强了未受损半球的神经元将轴突侧支延伸到失去正常神经支配的脑干和脊髓区域的能力。这种重新布线的同时还改进了受损肢体的使用。肌苷是一种天然存在的嘌呤核苷，它穿过细胞膜并激活Mst3b，Mst3b是一种蛋白激酶，在营养因子刺激轴突生长的细胞信号通路中发挥核心作用。肌苷的增强可塑性特性目前正在多发性硬化症和帕金森病患者中进行临床测试(帕金森氏病研究小组，2011年；Markowitz等人，2009年)。本研究的目的是利用我们用R21 AG-028680建立的猕猴皮质缺血性卒中模型，探讨肌苷对脑结构和精细运动灵巧度与人类高度相似的脑回脑动物皮质缺血后运动功能恢复的疗效。好了！

项目成果

Cell based therapy reduces secondary damage and increases extent of microglial activation following cortical injury.

基于细胞的治疗减少了继发性损伤并增加了皮质损伤后小胶质细胞的活化程度。

• DOI: 10.1016/j.brainres.2019.04.015
• 发表时间: 2019
• 期刊: Brain research
• 影响因子: 2.9
• 作者: Orczykowski,MaryE;Calderazzo,SamanthaM;Shobin,Eli;Pessina,MonicaA;Oblak,AdrianL;Finklestein,SethP;Kramer,BrianC;Mortazavi,Farzad;Rosene,DouglasL;Moore,TaraL
• 通讯作者: Moore,TaraL